Division of Hematology/Oncology

Faculty

faculty photo

Ronac Mamtani, MD, MSCE

Instructor A of Medicine
Attending Physician, Hematology-Oncology, Philadelphia Veterans Affairs Medical Center
Attending Physician, Hematology-Oncology, Hospital of the University of Pennsylvania
Instructor A in Medicine, University of Pennsylvania
Department: Medicine

Contact information
16 Penn Tower
3400 Spruce Street
Philadelphia, PA 19147
Office: 215-265-3040
Education:
BS
Cornell University, 2002.
MD (Internal Medicine)
Stony Brook School of Medicine, 2006.
MS (Clinical Epidemiology)
University of Pennsylvania , 2012.
Post-Graduate Training
Intern in Medicine, NY Hospital-Cornell Medical College, 2006-2007.
Resident in Medicine, NY Hospital-Cornell Medical College, 2007-2009.
Assistant Chief Resident in Medicine, NY Hospital-Cornell Medical College, 2008-2009.
Fellow in Hematology-Oncology, Hospital of the University of Pennsylvania, 2009-2012.
Certifications
American Board of Internal Medicine, 2009.
American Board of Internal Medicine (Medical Oncology), 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Jeurkar, N, Mamtani, R, Vaughn, DJ: Granulomatosis and Testicular Germ Cell Tumors. Urology 80(6): 1303-1306, DEC 2012.

Mamtani, R, Haynes, K, Bilker, WB, Vaughn, DJ, Strom, BL, Glanz, K, Lewis, JD: Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study. Journal Of The National Cancer Institute 104(18): 1411-1421, SEP 2012.

Mamtani, R, Haynes, K, Bilker, WB, Vaughn, DJ, Strom, BL, Glanz, K, Lewis, JD: Long-Term Therapy with Thiazolidinediones May Be Associated with Increased Incidence of Bladder Cancer. Pharmacoepidemiology And Drug Safety 21(3): 25, AUG 2012 Notes: Oral Abstract Presentation, International Society for Pharmacoepidemiology, Barcelona, 2012.

Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K, Lewis JD: Long-term therapy with thiazolidinediones and the risk of bladder cancer. American Society of Clinical Oncology, 2012 Notes: Oral Abstract Presentation, Chicago, 2012.

Mamtani, R, Vaughn, DJ: Vinflunine in the treatment of advanced bladder cancer. Expert Review Of Anticancer Therapy 11(1): 13-20, JAN 2011.

Brose MS, Troxel AB, Mamtani R: Phase II trial of everolimus with sorafenib for patients with differentiated thyroid cancer (DTC) who progress on sorafenib alone. American Society of Clinical Oncology 2010 Notes: Trials in Progress Poster Session, Chicago, 2010.

Focosi, D, Carson, K, Evens, A, Richey, E, Habermann, T, Seymour, J, Laubach, J, Bawn, S, Gordon, L, Winter, J, Vose, J, Zelenetz, A, Mamtani, R, Raisch, D, Dorshimer, G, Rosen, S, Muro, K, Gottardi-Littell, N, Talley, R, Sartor, O, Green, D, Major, E, Bennett, C, Petrini, M: Progressive Multifocal Leukoencephalopathy Following Rituximab Therapy in HIV Negative Patients: A Report of 56 Cases from the Research on Adverse Drug Event and Reports (RADAR) Project. Haematologica-the Hematology Journal 94: 445, JUN 2009.

Carson Kenneth R, Evens Andrew M, Richey Elizabeth A, Habermann Thomas M, Focosi Daniele, Seymour John F, Laubach Jacob, Bawn Susie D, Gordon Leo I, Winter Jane N, Furman Richard R, Vose Julie M, Zelenetz Andrew D, Mamtani Ronac, Raisch Dennis W, Dorshimer Gary W, Rosen Steven T, Muro Kenji, Gottardi-Littell Numa R, Talley Robert L, Sartor Oliver, Green David, Major Eugene O, Bennett Charles L: Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113(20): 4834-40, May 2009.

Mamtani R, Mamtani R.: Ayurveda and Yoga in Cardiovascular Diseases. Complementary and Integrative Therapies in Cardiovascular Diseases. W. Frishman, M. Weintraub, and M. Micozzi, Eds. (eds.). Elsevier Mosby. Page: 168-181, 2006.

Cole, S, Kuriakose, E, Mamtani, R, Ahmad, T: Are antidepressants effective in the medically ill? A Scorecard Approach. Psychosom Med. 68(1): A-85, 2006 Notes: Abstract # 1666.

back to top
Last updated: 04/02/2013
The Trustees of the University of Pennsylvania
 

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter